Skip to main content
Erschienen in: Updates in Surgery 2/2023

17.09.2022 | Review Article

Does radiomics play a role in the diagnosis, staging and re-staging of gastroesophageal junction adenocarcinoma?

verfasst von: Martina Mori, Diego Palumbo, Francesco De Cobelli, Claudio Fiorino

Erschienen in: Updates in Surgery | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Radiomics is an emerging field of investigation in medicine consisting in the extraction of quantitative features from conventional medical images and exploring their potentials in improving diagnosis, prognosis and outcome prediction after therapy. Clinical applications are still limited, mostly due to reproducibility and repeatability issues as well as to limited interpretability of predictive radiomic-based features/signatures. In the specific case of gastroesophageal junction (GEJ) adenocarcinoma, the expectancies are particularly high, mainly due to its increasing incidence and to the limited performance of conventional imaging techniques in assessing correct diagnosis and accurate pre-surgical tumor characterization. Accordingly, current literature was reviewed, emphasizing the methodological quality. In addition, papers were scored according to the Radiomic Quality Score (RQS), weighting more the clinical applicability and generalizability of the resulting models. According to the criteria of the search, only two papers were retained: the resulting technical quality was relatively high for both, while the corresponding RQS were 15 and 19 (on a scale of 31). Although the potentials of radiomics in the setting of GEJ adenocarcinoma are relevant, they remain largely unexplored, warranting an urgent need of high-quality, possibly prospective, multicenter studies.
Literatur
1.
Zurück zum Zitat Siewert J, Stein H (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459CrossRef Siewert J, Stein H (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459CrossRef
2.
Zurück zum Zitat Ichihara S (2017) Considering the esophagogastric junction as a ‘zone.’ Dig End 29(2):3–10CrossRef Ichihara S (2017) Considering the esophagogastric junction as a ‘zone.’ Dig End 29(2):3–10CrossRef
3.
Zurück zum Zitat Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual 8th edition 2017. Springer, ChamCrossRef Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual 8th edition 2017. Springer, ChamCrossRef
4.
Zurück zum Zitat Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothor Surg 6(2):119–130CrossRef Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothor Surg 6(2):119–130CrossRef
5.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef
6.
Zurück zum Zitat Liu K, Yang K, Zhang W et al (2016) Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988–2012: a single-institution, high-volume experience in China. Ann Surg 263(1):88–95CrossRef Liu K, Yang K, Zhang W et al (2016) Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988–2012: a single-institution, high-volume experience in China. Ann Surg 263(1):88–95CrossRef
7.
Zurück zum Zitat ACS American cancer society, facts and figures 2013 ACS American cancer society, facts and figures 2013
8.
Zurück zum Zitat Kamangar FJ, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Clin Oncol 24(14):2137–2150 Kamangar FJ, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Clin Oncol 24(14):2137–2150
9.
Zurück zum Zitat Ajani JA, D’Amico TA, Almhanna K et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. JNCCN 17(7):855–883 Ajani JA, D’Amico TA, Almhanna K et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. JNCCN 17(7):855–883
10.
Zurück zum Zitat van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRef van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRef
11.
Zurück zum Zitat Knight WRC, Zylstra J, Van Hemelrijck M et al (2018) Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy. BJS Open 1(6):182–190CrossRef Knight WRC, Zylstra J, Van Hemelrijck M et al (2018) Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy. BJS Open 1(6):182–190CrossRef
12.
Zurück zum Zitat Shapiro J, Van Lanscho JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRef Shapiro J, Van Lanscho JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRef
13.
Zurück zum Zitat Stahl M, Walz MK, Riera-Knorrenschild J et al (2017) Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial. Eur J Cancer 81:183–190CrossRef Stahl M, Walz MK, Riera-Knorrenschild J et al (2017) Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial. Eur J Cancer 81:183–190CrossRef
14.
Zurück zum Zitat De Cobelli F, Palumbo D, Albarello L et al (2020) Esophagus and stomach: is there a role for MR imaging? Magn Reson Imaging Clin N Am 28(1):1–15CrossRef De Cobelli F, Palumbo D, Albarello L et al (2020) Esophagus and stomach: is there a role for MR imaging? Magn Reson Imaging Clin N Am 28(1):1–15CrossRef
15.
Zurück zum Zitat Palumbo D, Mapelli P, Nicoletti V et al (2020) Imaging in evaluation of response to neo-adjuvant treatment. Ann Esophagus 3:38CrossRef Palumbo D, Mapelli P, Nicoletti V et al (2020) Imaging in evaluation of response to neo-adjuvant treatment. Ann Esophagus 3:38CrossRef
16.
Zurück zum Zitat D’Journo XB (2018) Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 10:2671–2681CrossRef D’Journo XB (2018) Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 10:2671–2681CrossRef
17.
Zurück zum Zitat Yuan Y, Chen L, Ren S et al (2019) Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla. Cancer Imaging 19(1):83CrossRef Yuan Y, Chen L, Ren S et al (2019) Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla. Cancer Imaging 19(1):83CrossRef
18.
Zurück zum Zitat Linder G, Korsavidou-Hult N, Bjerner T et al (2019) 18F-FDG-PET/MRI in preoperative staging of oesophageal and gastroesophageal junctional cancer (2019). Clin Radiol 74(9):718–725CrossRef Linder G, Korsavidou-Hult N, Bjerner T et al (2019) 18F-FDG-PET/MRI in preoperative staging of oesophageal and gastroesophageal junctional cancer (2019). Clin Radiol 74(9):718–725CrossRef
19.
Zurück zum Zitat Yip C, Cook GJ, Landau DB et al (2016) Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer. Dis Esophagus 29(2):116–130CrossRef Yip C, Cook GJ, Landau DB et al (2016) Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer. Dis Esophagus 29(2):116–130CrossRef
20.
Zurück zum Zitat Belmouhand M, Löfgren J, Johannesen HH et al (2019) Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction. Abdom Radiol 44(3):836–844CrossRef Belmouhand M, Löfgren J, Johannesen HH et al (2019) Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction. Abdom Radiol 44(3):836–844CrossRef
21.
Zurück zum Zitat Giganti F, Ambrosi A, Petrone MC et al (2016) Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study. Br J Radiol 89(1068):20160087CrossRef Giganti F, Ambrosi A, Petrone MC et al (2016) Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study. Br J Radiol 89(1068):20160087CrossRef
22.
Zurück zum Zitat Borggreve AS, Mook S, Verheij M et al (2018) Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study. BMC Cancer 18(1):1006CrossRef Borggreve AS, Mook S, Verheij M et al (2018) Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study. BMC Cancer 18(1):1006CrossRef
23.
Zurück zum Zitat Yip SSF, Aerts HJWL (2016) Applications and limitations of radiomics. Phys Med Biol 61(13):R150–R166CrossRef Yip SSF, Aerts HJWL (2016) Applications and limitations of radiomics. Phys Med Biol 61(13):R150–R166CrossRef
24.
Zurück zum Zitat Weber MA, Bender K, von Gall CC et al (2013) Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction. J Gastrointestin Liver Dis 22(1):45–52 Weber MA, Bender K, von Gall CC et al (2013) Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction. J Gastrointestin Liver Dis 22(1):45–52
25.
Zurück zum Zitat Borggreve AS, Heethuis SE, Boekhoff MR et al (2020) Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer. Eur Radiol 30(4):1896–1907CrossRef Borggreve AS, Heethuis SE, Boekhoff MR et al (2020) Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer. Eur Radiol 30(4):1896–1907CrossRef
26.
Zurück zum Zitat Lorenzen S, von Gall C, Stange A et al (2011) Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial. BMC Cancer 11:266CrossRef Lorenzen S, von Gall C, Stange A et al (2011) Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial. BMC Cancer 11:266CrossRef
27.
Zurück zum Zitat Fiorino C, Gumina C, Passoni P et al (2018) A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiother Oncol 128:564–568CrossRef Fiorino C, Gumina C, Passoni P et al (2018) A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiother Oncol 128:564–568CrossRef
28.
Zurück zum Zitat Broggi S, Passoni P, CalogeroGumina C et al (2020) Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration. Radiother Oncol 149:174–180CrossRef Broggi S, Passoni P, CalogeroGumina C et al (2020) Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration. Radiother Oncol 149:174–180CrossRef
29.
Zurück zum Zitat Dinapoli N, Barbaro B, Gatta R et al (2018) Magnetic resonance, vendor-independent, intensity histogram analysis predicting pathologic complete response after radiochemotherapy of rectal cancer. N Int J Radiat oncol Biol Phys 102(4):765–774CrossRef Dinapoli N, Barbaro B, Gatta R et al (2018) Magnetic resonance, vendor-independent, intensity histogram analysis predicting pathologic complete response after radiochemotherapy of rectal cancer. N Int J Radiat oncol Biol Phys 102(4):765–774CrossRef
30.
Zurück zum Zitat Lambin P, Rios-Velazquez E, Leijeneer R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRef Lambin P, Rios-Velazquez E, Leijeneer R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRef
31.
Zurück zum Zitat Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin oncol 14(12):749–762CrossRef Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin oncol 14(12):749–762CrossRef
32.
Zurück zum Zitat Velazquez AHJWL, RalphLeijenaar ERRTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 3(5):4006 Velazquez AHJWL, RalphLeijenaar ERRTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 3(5):4006
33.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures. They Are Data Radiol 278(2):563–577 Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures. They Are Data Radiol 278(2):563–577
34.
Zurück zum Zitat Avanzo M, Stancanello J, El Naqa I (2017) Beyond imaging: the promise of radiomics. Phys Med 38:122–139CrossRef Avanzo M, Stancanello J, El Naqa I (2017) Beyond imaging: the promise of radiomics. Phys Med 38:122–139CrossRef
35.
Zurück zum Zitat Van Timmeren JE, Cester D, Tanadini-Lang, et al (2020) Radiomics in medical imaging-"how-to" guide and critical reflection. Insight Imaging 11:91CrossRef Van Timmeren JE, Cester D, Tanadini-Lang, et al (2020) Radiomics in medical imaging-"how-to" guide and critical reflection. Insight Imaging 11:91CrossRef
36.
Zurück zum Zitat Vallieres M, Zwanenburg A, Badic B et al (2018) Responsible radiomics research for faster clinical translation. J Nucl Med 59(2):189–193CrossRef Vallieres M, Zwanenburg A, Badic B et al (2018) Responsible radiomics research for faster clinical translation. J Nucl Med 59(2):189–193CrossRef
37.
Zurück zum Zitat Belli ML, Mori M, Broggi S et al (2018) Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Phys Med 49:105–111CrossRef Belli ML, Mori M, Broggi S et al (2018) Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Phys Med 49:105–111CrossRef
38.
Zurück zum Zitat Presotto L, Bettinardi V, De Bernardi E et al (2018) PET textural features stability and pattern discrimination power for radiomics analysis: an “ad-hoc” phantoms study. Phys Med 50:66–74CrossRef Presotto L, Bettinardi V, De Bernardi E et al (2018) PET textural features stability and pattern discrimination power for radiomics analysis: an “ad-hoc” phantoms study. Phys Med 50:66–74CrossRef
39.
Zurück zum Zitat Mori M, Benedetti G, Partelli S et al (2019) Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. Phys Med 57:41–46CrossRef Mori M, Benedetti G, Partelli S et al (2019) Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. Phys Med 57:41–46CrossRef
40.
Zurück zum Zitat Whybra P, Foley K, Parkinson C et al (2018) Effect of interpolation on 3D texture analysis of PET imaging in oesophageal cancer. Radiother Oncol 127(Supp 1):S1167-1168 Whybra P, Foley K, Parkinson C et al (2018) Effect of interpolation on 3D texture analysis of PET imaging in oesophageal cancer. Radiother Oncol 127(Supp 1):S1167-1168
41.
Zurück zum Zitat Loi S, Mori M, Benedetti G et al (2020) Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms. Phys Med 76:125–133CrossRef Loi S, Mori M, Benedetti G et al (2020) Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms. Phys Med 76:125–133CrossRef
42.
Zurück zum Zitat Zwanenburg A, Leger S, Vallières M et al (2016) Initiative, for the I. B. S. Image biomarker standardisation initiative arXiv:1612.07003 Zwanenburg A, Leger S, Vallières M et al (2016) Initiative, for the I. B. S. Image biomarker standardisation initiative arXiv:​1612.​07003
43.
Zurück zum Zitat Zwanenburg A et al (2018) PO-0981: Results from the image biomarker standardisation initiative. Radiother Oncol 127:S543–S544CrossRef Zwanenburg A et al (2018) PO-0981: Results from the image biomarker standardisation initiative. Radiother Oncol 127:S543–S544CrossRef
44.
Zurück zum Zitat Zwanenburg A, Vallières M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 00:1–11 Zwanenburg A, Vallières M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 00:1–11
45.
Zurück zum Zitat Klaassen R, Larue RTHM, Mearadji B et al (2018) Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients. PLoS ONE 13(11):e0207362CrossRef Klaassen R, Larue RTHM, Mearadji B et al (2018) Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients. PLoS ONE 13(11):e0207362CrossRef
46.
Zurück zum Zitat Kage A, Raithe M, Zopf S et al (2009) Narrow-band imaging for the computer-assisted diagnosis in patients with barrett’s esophagus. Progress Biomed Opt Imaging Proc SPIE 7260:72603S Kage A, Raithe M, Zopf S et al (2009) Narrow-band imaging for the computer-assisted diagnosis in patients with barrett’s esophagus. Progress Biomed Opt Imaging Proc SPIE 7260:72603S
47.
Zurück zum Zitat Li J, Liu Y, Fu J et al (2020) CT features of adenocarcinoma of esophagogastric junction after neoadjuvant chemotherapy. Chin J Dig Surg 19(6):686–693 Li J, Liu Y, Fu J et al (2020) CT features of adenocarcinoma of esophagogastric junction after neoadjuvant chemotherapy. Chin J Dig Surg 19(6):686–693
48.
Zurück zum Zitat Wang Q, Zhou S, Court LE et al (2017) Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery. Phys Imaging Radiat Oncol 3:37–42CrossRef Wang Q, Zhou S, Court LE et al (2017) Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery. Phys Imaging Radiat Oncol 3:37–42CrossRef
49.
Zurück zum Zitat Chang X, Guo X, Li X et al (2021) Potential value of radiomics in the identification of stage T3 and T4a esophagogastric junction adenocarcinoma based on contrast-enhanced CT images. Front Oncol 3(11):627947CrossRef Chang X, Guo X, Li X et al (2021) Potential value of radiomics in the identification of stage T3 and T4a esophagogastric junction adenocarcinoma based on contrast-enhanced CT images. Front Oncol 3(11):627947CrossRef
50.
Zurück zum Zitat Hatt M, Tixier F, Cheze Le Rest C et al (2013) Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40(11):1662–1671CrossRef Hatt M, Tixier F, Cheze Le Rest C et al (2013) Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40(11):1662–1671CrossRef
51.
Zurück zum Zitat Zhang H, Tan S, Chen W et al (2014) Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics. Int J Radiat Oncol Biol Phys 88(1):195–203CrossRef Zhang H, Tan S, Chen W et al (2014) Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics. Int J Radiat Oncol Biol Phys 88(1):195–203CrossRef
52.
Zurück zum Zitat Yip SSF, Coroller TP, Sanford NN et al (2016) Relationship between the temporal changes in positron-emission-tomography-imaging-based textural features and pathologic response and survival in esophageal cancer patients. Front Oncol 6:72CrossRef Yip SSF, Coroller TP, Sanford NN et al (2016) Relationship between the temporal changes in positron-emission-tomography-imaging-based textural features and pathologic response and survival in esophageal cancer patients. Front Oncol 6:72CrossRef
53.
Zurück zum Zitat Dong D, Fang MJ, Tang L et al (2020) Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol 31(7):912–920CrossRef Dong D, Fang MJ, Tang L et al (2020) Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol 31(7):912–920CrossRef
54.
Zurück zum Zitat Giganti F, Marra P, Ambrosi A et al (2017) Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: comparison with tumour regression grade at final histology. Eur J Radiol 90:129–137CrossRef Giganti F, Marra P, Ambrosi A et al (2017) Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: comparison with tumour regression grade at final histology. Eur J Radiol 90:129–137CrossRef
55.
Zurück zum Zitat Giganti F, Antunes S, Salerno A et al (2017) Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker. Eur Radiol 27(5):1831–1839CrossRef Giganti F, Antunes S, Salerno A et al (2017) Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker. Eur Radiol 27(5):1831–1839CrossRef
56.
Zurück zum Zitat Sun Sun RJ, Fang MJ, Tang L et al (2020) CT-based deep learning radiomics analysis for evaluation of serosa invasion in advanced gastric cancer. Eur J Radiol 132:109277CrossRef Sun Sun RJ, Fang MJ, Tang L et al (2020) CT-based deep learning radiomics analysis for evaluation of serosa invasion in advanced gastric cancer. Eur J Radiol 132:109277CrossRef
57.
Zurück zum Zitat Jiang Y, Chen C, Xie J et al (2018) Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. Biomedicine 36:171–182 Jiang Y, Chen C, Xie J et al (2018) Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. Biomedicine 36:171–182
58.
Zurück zum Zitat Parkinson C, Foley K, Whybra P et al (2018) Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methods. EJNMMI Res 8:29CrossRef Parkinson C, Foley K, Whybra P et al (2018) Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methods. EJNMMI Res 8:29CrossRef
59.
Zurück zum Zitat Simoni N, Rossi G, Benetti G et al (2020) 18F-FDG PET/CT metrics are correlated to the pathological response in esophageal cancer patients treated with induction chemotherapy followed by neoadjuvant chemo-radiotherapy. Front Oncol 10:599907CrossRef Simoni N, Rossi G, Benetti G et al (2020) 18F-FDG PET/CT metrics are correlated to the pathological response in esophageal cancer patients treated with induction chemotherapy followed by neoadjuvant chemo-radiotherapy. Front Oncol 10:599907CrossRef
60.
Zurück zum Zitat Lichtenberger JP, Zeman MN, Dulberger AR et al (2021) Esophageal neoplasms: radiologic-pathologic correlation. Radiol Clin N Am 59(2):205–217CrossRef Lichtenberger JP, Zeman MN, Dulberger AR et al (2021) Esophageal neoplasms: radiologic-pathologic correlation. Radiol Clin N Am 59(2):205–217CrossRef
61.
Zurück zum Zitat Liu S, Shi H, Ji C et al (2018) CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers. Sci Rep 8:11844CrossRef Liu S, Shi H, Ji C et al (2018) CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers. Sci Rep 8:11844CrossRef
62.
Zurück zum Zitat Kawahara D, Murakami Y, Tani S et al (2021) A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning. Br J Radiol 94(1124):20210525CrossRef Kawahara D, Murakami Y, Tani S et al (2021) A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning. Br J Radiol 94(1124):20210525CrossRef
Metadaten
Titel
Does radiomics play a role in the diagnosis, staging and re-staging of gastroesophageal junction adenocarcinoma?
verfasst von
Martina Mori
Diego Palumbo
Francesco De Cobelli
Claudio Fiorino
Publikationsdatum
17.09.2022
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 2/2023
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-022-01377-4

Weitere Artikel der Ausgabe 2/2023

Updates in Surgery 2/2023 Zur Ausgabe

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.